<- Go Home
Vetoquinol SA
Vetoquinol SA, a veterinary pharmaceutical company, engages in designing, developing, and selling of veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region. It offers products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; antibiotics; reproduction; behavior management; internal medicine; and cardio-nephrology. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA operates as a subsidiary of Soparfin SCA.
Market Cap
EUR 833.3M
Volume
4.9K
Cash and Equivalents
EUR 221.1M
EBITDA
EUR 103.4M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
EUR 308.0M
Profit Margin
58.58%
52 Week High
EUR 91.50
52 Week Low
EUR 67.20
Dividend
1.30%
Price / Book Value
1.41
Price / Earnings
14.53
Price / Tangible Book Value
2.13
Enterprise Value
EUR 627.6M
Enterprise Value / EBITDA
5.73
Operating Income
EUR 79.8M
Return on Equity
9.82%
Return on Assets
6.62
Cash and Short Term Investments
EUR 221.1M
Debt
EUR 15.3M
Equity
EUR 591.4M
Revenue
EUR 525.7M
Unlevered FCF
EUR 49.5M
Sector
Pharmaceuticals
Category
N/A